🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Aalborg
Clinical trial register · Denmark

Clinical Trials in Aalborg, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Denmark and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2473 matching records held by the registry are in this view. Synced 26 Sep 2026, 19:46 UTC
2473
Studies in scope
all four open statuses
1402
Recruiting now
open to new participants
436
Lead sponsors
across recruiting studies
Top sites
Copenhagen 971 Aarhus 588 Odense 439 Aalborg 382 Herlev 309
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Aalborg University Hospital35 University of Aarhus22 AstraZeneca22 Merck Sharp & Dohme LLC17 Aalborg University16
Site location
Copenhagen971 Aarhus588 Odense439 Aalborg382 Herlev309
All 128 locations
Target enrolment
to

Trials with a site in Aalborg

382 of 2473 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Denmark
Start
Recruiting
Profiling the Dynamic of Binge Eating Disorder (PRODY-BED)
NCT05726721Binge-Eating Disorder, Emotion Regulation, Executive Dysfunction, Eating Behavior
Aarhus University Hospital
Observational
180
Aarhus, Aalborg, Copenhagen NV
2023-07-03
Active, closed
A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
NCT05878769Chronic Obstructive Pulmonary Disease
DrugAstegolimab
Hoffmann-La Roche
Phase 3
2,000
Aalborg, Hellerup, Hvidovre, Odense C, Roskilde, Vejle
2023-06-28
Recruiting
Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease
NCT05701358Acute Myocardial Infarction, Coronary Artery Disease
Population Health Research Institute
Not applicable
5,100
Aalborg, Aarhus, Copenhagen
2023-06-22
Recruiting
The Danish Out-of-Hospital Cardiac Arrest Study
NCT05895838Out-Of-Hospital Cardiac Arrest, Post-Cardiac Arrest Syndrome
DrugsOlanzapine·Dexamethasone
Christian Hassager
Phase 3
1,000
Copenhagen, Aalborg, Aarhus, Køge, Odense
2023-06-16
Recruiting
Gemcitabine Versus Reduced-dose Combination Chemotherapy in Fragile Patients with Non-resectable Pancreatic Cancer
NCT05841420Pancreas Cancer, Non-Resectable Pancreas Carcinoma
DrugsAbraxane·Nab-paclitaxel·Gemcitabine
Morten Ladekarl
Phase 2
98
Aalborg
2023-06-12
By invitation
Long-term Extension Study to Assess Adverse Events of Oral Atogepant Tablets in Pediatric Participants (6 to 17 Years of Age) With Migraine
NCT05707949Migraine Prophylaxis
DrugAtogepant
AbbVie
Phase 3
650
Herlev, Herning, Aalborg
2023-06-05
Recruiting
Scandinavian Trial of Uncomplicated Aortic Dissection Therapy
NCT05215587Aortic Dissection
University of Aarhus
Not applicable
554
Aalborg, Aarhus, Copenhagen, Odense
2023-05-24
Recruiting
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
NCT05711394Episodic Migraine
DrugAtogepant
AbbVie
Phase 3
450
Herlev, Herning, Aalborg
2023-05-01
Active, closed
A Real-world, Head-to-head Comparison of Dupilumab Versus Mepolizumab in Danish Patients With Chronic Rhinosinusitis With Nasal Polyps
NCT05942222Chronic Rhinosinusitis With Nasal Polyps, Asthma; Eosinophilic, Eosinophilia
DrugsNucala·Mepolizumab·Dupilumab
Rigshospitalet, Denmark
Phase 4
220
Aalborg, Aarhus, Copenhagen, Esbjerg, Herning, Hillerød, Køge, Odense
2023-04-27
Recruiting
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
NCT04124120Heart Diseases, Coronary Artery Disease, Coronary Artery Bypass Grafting
Weill Medical College of Cornell University
Not applicable
2,300
Aalborg, Copenhagen
2023-04-17
Active, closed
Treatment of Posterior Benign Paroxysmal Positional Vertigo With Mechanical Rotational Chair.
NCT05834452Benign Paroxysmal Positional Vertigo, BPPV
Aalborg University Hospital
Not applicable
128
Aalborg
2023-04-12
Active, closed
A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies
NCT05794906Biochemically Recurrent Prostate Cancer
DrugDarolutamide
Bayer
Phase 3
985
Aarhus N, Aalborg, Næstved, København Ø
2023-04-03
Active, closed
The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Atrial Fibrillation
NCT03129490Atrial Fibrillation, Atrial Flutter
DrugsDabigatran Etexilate·Edoxaban·Apixaban·Rivaroxaban
Herlev and Gentofte Hospital
Phase 4
11,000
Aalborg, Aarhus, Ballerup Municipality, Copenhagen, Copenhagen NV, Copenhagen S, Copenhagen Ø, Esbjerg
2023-04-01
Recruiting
GO-PLAY - Early Family-Centered Intervention for Infants With High-Risk of Cerebral Palsy
NCT05883969Cerebral Palsy
Rigshospitalet, Denmark
Not applicable
60
Aalborg, Aarhus
2023-04-01
Not yet open
Dual Mobility Cup Versus Unipolar Cup
NCT04685239Dislocation, Hip
Northern Orthopaedic Division, Denmark
Not applicable
1,000
Aalborg
2023-04-01
Recruiting
CP-EDIT: Cerebral Palsy - Early Diagnosis and Intervention Trial
NCT05835674Cerebral Palsy
Rigshospitalet, Denmark
Observational
500
Aalborg, Aarhus, Herlev, Copenhagen
2023-04-01
Active, closed
A Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma
NCT05572515Relapsed or Refractory Multiple Myeloma
DrugsTeclistamab·Carfilzomib·Pomalidomide·Bortezomib
Janssen Research & Development, LLC
Phase 3
614
Aalborg, Aarhus, Copenhagen, Herning, Odense C, Vejle
2023-03-29
Active, closed
A Study of Nemtabrutinib vs Chemoimmunotherapy for Participants With Previously Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Without TP53 Aberrations (MK-1026-008, BELLWAVE-008)
NCT05624554Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
DrugsNemtabrutinib·Riabni·Ruxience·Truxima
Merck Sharp & Dohme LLC
Phase 3
300
Aarhus, Aalborg, Odense C, Vejle
2023-03-16
Recruiting
Paediatric Autism Communication Therapy (PACT) in Children With Autism Spectrum Disorder
NCT05673096Autism Spectrum Disorder
University of Southern Denmark
Not applicable
280
Aabenraa, Aalborg, Aarhus, Hellerup, Odense, Roskilde
2023-03-13
Active, closed
Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD
NCT05711940Treatment Resistant Depression
DrugPsilocybin
COMPASS Pathways
Phase 3
572
Aalborg
2023-02-14
Active, closed
Bicarbonate for In-Hospital Cardiac Arrest
NCT05564130Cardiac Arrest
DrugSodium Bicarbonate
Lars Wiuff Andersen
Phase 4
778
Aabenraa, Aalborg, Aarhus, Bispebjerg, Copenhagen, Esbjerg, Gentofte Municipality, Gødstrup
2023-02-06
Recruiting
Immunotherapy in Patients With Early dMMR Rectal Cancer
NCT05732389Cancer of Rectum
DrugsYervoy·Opdivo·Ipilimumab·Nivolumab
Odense University Hospital
Phase 2
39
Aalborg, Aarhus, Copenhagen, Odense, Roskilde
2023-02-01
Recruiting
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)
NCT05580562H3 K27M, Glioma
DrugDordaviprone
Jazz Pharmaceuticals
Phase 3
510
Copenhagen, Aalborg, Odense
2023-01-23
Active, closed
Treat-to-target Prednisolon Taper in Patients With Polymyalgia Rheumatica
NCT05636501Polymyalgia Rheumatica
Aarhus University Hospital
Not applicable
120
Aalborg, Aarhus, Herning, Hjørring, Horsens, Silkeborg
2023-01-12
Recruiting
Implementing ctDNA and Circular DNA in Patients With Localized Pancreatic Cancer
NCT05788744Resectable Pancreatic Cancer
Copenhagen University Hospital at Herlev
Not applicable
1,000
Aalborg, Aarhus, Copenhagen, Herlev, Odense
2023-01-01
Recruiting
Danish Diabetes Birth Registry 2
NCT05678543Pregnancy in Diabetic, Type 1 Diabetes, Type 2 Diabetes, Parents
Odense University Hospital
Observational
2,500
Aalborg, Aarhus, Copenhagen, Odense
2023-01-01
Recruiting
The Voided Urinary, Perineal, and Faecal Microbiota Among Children and Adolescents - the PpUF-study.
NCT07535619Urinary Incontinence, Daytime Wetting, Urination Disorders, Urologic Diseases
Aalborg University Hospital
Observational
110
Aalborg, Aarhus, Herning, Hjørring
2022-12-14
Active, closed
Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial
NCT05581303Atherosclerotic Cardiovascular Disease
DrugOlpasiran
Amgen
Phase 3
7,297
Aalborg, Aarhus N, Copenhagen O, Esbjerg, Gandrup, Herlev, Herning, Holbæk
2022-12-14
Recruiting
Efficacy and Safety of XyloCore Peritoneal Dialysis Solution.
NCT03994471End Stage Renal Disease
Iperboreal Pharma Srl
Phase 3
170
Aalborg, Aarhus, Roskilde
2022-12-14
Recruiting
INfluenza VaccInation To Mitigate typE 1 Diabetes
NCT05585983Diabetes Mellitus, Type 1
Aarhus University Hospital
Phase 4
100
Aalborg, Aarhus, Copenhagen, Herning, Holbæk, Nykøbing Falster, Randers, Roskilde
2022-12-14
Active, closed
A Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in Participants With International Prognostic Scoring System Revised (IPSS-R) Low- or Intermediate-risk Myelodysplastic Syndrome (MDS)
NCT05469737Myelodysplastic Syndromes
DrugAzacitidine
Bristol-Myers Squibb
Phase 2/3
230
Aarhus, Aalborg
2022-12-14
Recruiting
Lithium Versus Cariprazine in the Acute Phase Treatment of Bipolar Depression (DUAG9)
NCT05913947Depression, Bipolar
DrugsCariprazine·Lithium
Aalborg University Hospital
Phase 4
122
Aalborg
2022-12-13
Recruiting
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
NCT05624450Viral Lung Infection and Acute Respiratory Failure
DrugTozorakimab
AstraZeneca
Phase 3
3,527
Aalborg, Aarhus N, Copenhagen, Copenhagen Ø, Herning, Hillerød, Hvidovre, Kolding
2022-12-13
Active, closed
CORE-OLE: A Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Participants With Severe Hypertriglyceridemia (SHTG)
NCT05681351Severe Hypertriglyceridemia
DrugOlezarsen
Ionis Pharmaceuticals, Inc.
Phase 3
885
Aalborg, Aarhus, Esbjerg, Viborg
2022-12-13
Active, closed
Safety and Efficacy of ALXN1720 in Adults With Generalized Myasthenia Gravis
NCT05556096Generalized Myasthenia Gravis
Alexion Pharmaceuticals, Inc.
Phase 3
260
Aalborg, Copenhagen
2022-11-21
Active, closed
A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products
NCT05476926Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion, Branch Retinal Vein Occlusion
DrugsVabysmo·Faricimab
Hoffmann-La Roche
Observational
6,000
Aalborg, Glostrup Municipality, Roskilde
2022-11-21
Recruiting
A Multicenter Phase II Study of Stereotactic Radiotherapy for Centrally Located Lung Tumors (STRICT-LUNG STUDY) and Ultra-centrally Located Lung Tumors (STAR-LUNG STUDY).
NCT05354596Lung Cancer, Metastases to Lung, Radiotherapy Side Effect
Rigshospitalet, Denmark
Not applicable
138
Aalborg, Aarhus, Copenhagen, Herlev, Odense, Vejle
2022-11-01
Recruiting
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
NCT05552222Multiple Myeloma
DrugsTalquetamab·Teclistamab·Daratumumab·Lenalidomide
Janssen Research & Development, LLC
Phase 3
1,590
Aalborg, Herning, Roskilde, Vejle
2022-10-25
Recruiting
A Trial to Compare Efficacy and Tolerability of Plenvu® and Picoprep® as Cleansing Agents Before Colonoscopy
NCT05436054Colon Disease
DrugsPicoprep·Plenvu
Aalborg University Hospital
Phase 4
400
Aalborg
2022-10-01
Recruiting
Absolute Coronary Flow in Patients With Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block With Cardiac Resynchronization Therapy
NCT05564689Left Bundle-Branch Block, Heart Failure, Cardiac Resynchronization Therapy, Dilated Cardiomyopathy
Ashkan Eftekhari
Observational
60
Aalborg
2022-09-29
Active, closed
A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
NCT05242484Colitis, Ulcerative
DrugsJNJ-78934804·Golimumab·Guselkumab
Janssen Research & Development, LLC
Phase 2
577
Aalborg, Aarhus, Copenhagen, Herlev, Odense
2022-09-19
Active, closed
IMPROVE-pT1: Accurate Allocation of Completion Resection in Early Colorectal Cancer
NCT06040632Colorectal Cancer, Colorectal Polyp, Colorectal Cancer Stage I
University of Aarhus
Observational
67
Copenhagen, Herlev, Aarhus, Herning, Horsens, Randers, Viborg, Aalborg
2022-09-01
Active, closed
Effect of Single vs Multiple Prophylactic Antibiotic Doses on PJI Following Primary THA in Patients With a Fracture
NCT05530174Fracture of Hip, Total Hip Arthroplasty, Prosthetic-joint Infection, Fracture Acetabular
Soren Overgaard
Not applicable
2,000
Aabenraa, Aalborg, Aarhus, Aarhus C, Brøndby, Copenhagen NV, Copenhagen Ø, Esbjerg
2022-09-01
Recruiting
Incremental Value of Magnetic Resonance Imaging in Selection of Pancreatic Cancer Patients for Surgery
NCT05428358Pancreatic Cancer, Pancreatic Neoplasm, Liver Metastases
University of Aarhus
Not applicable
200
Aalborg, Aarhus, Copenhagen
2022-08-30
Active, closed
A Study to Learn About the Safety of Diranersen (BIIB080) Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age
NCT05399888Mild Cognitive Impairment Due to Alzheimer's Disease, Alzheimer's Disease Dementia
Biogen
Phase 2
416
Aalborg, Copenhagen
2022-08-24
Recruiting
Compassionate Communication and Advance Care Planning to Improve End of Life Care in Treatment of Hematological Disease (ACT)
NCT05444348Multiple Myeloma, Myelodysplastic Syndromes, Lymphoma, Acute Myeloid Leukemia
Christoffer Johansen
Not applicable
920
Aalborg, Aarhus, Esbjerg, Herning, Odense, Roskilde, Vejle
2022-08-01
Recruiting
Food Intake Among Women and Men in Fertility Treatment
NCT05454046Infertility
Aalborg University Hospital
Observational
4,000
Aalborg, Aarhus, Copenhagen, Herlev, Horsens, Odense, Skive
2022-08-01
Recruiting
Prevention of Oxaliplatin-induced Nerve Damage in the Body's Extremities
NCT05404230Peripheral Neuropathy, Colorectal Cancer
Vejle Hospital
Not applicable
120
Aalborg, Aarhus, Sønderborg, Vejle
2022-07-15
Active, closed
A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer
NCT05217446Metastatic Colorectal Cancer
DrugsEncorafenib·Erbitux·Cetuximab·Keytruda
Pfizer
Phase 2
108
Copenhagen, Aalborg, Vejle
2022-07-11
Active, closed
Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) Versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
NCT04975997Multiple Myeloma
DrugsIberdomide·Bortezomib·Daratumumab·Dexamethasone
Celgene
Phase 3
939
Aalborg, Odense, Roskilde
2022-06-23
Recruiting
Reduced Antithrombotic Strategy for High Bleeding Risk Patients With Myocardial Infarction
NCT05262803Myocardial Infarction
Rikke Sorensen
Phase 4
2,808
Aalborg, Copenhagen, Hellerup, Odense, Roskilde, Skejby
2022-06-17
Active, closed
A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma
NCT05283720Non-Hodgkin Lymphoma
DrugsGolcadomide·Polatuzumab Vedotin·Epcoritamab·Doxorubicin Hydrochloride
Genmab
Phase 2
264
Aarhus, Aalborg
2022-06-14
Active, closed
IO102-IO103 in Combination With Pembrolizumab Versus Pembrolizumab Alone in Advanced Melanoma (IOB-013 / KN-D18)
NCT05155254Metastatic Melanoma, Unresectable Melanoma
DrugsIO102-IO103·Pembrolizumab
IO Biotech
Phase 3
407
Aalborg, Aarhus, Herlev, Odense
2022-05-17
Active, closed
Characterisation of Low Frequency Hearing and Vestibular Function in Patients Undergoing Cochlear Implantation
NCT06021132Hearing Loss, Sensorineural, Hearing Loss, Bilateral
Aalborg University Hospital
Observational
39
Aalborg
2022-05-01
Recruiting
Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome
NCT04920149Lynch Syndrome, Colon Cancer, Colon Neoplasm
DrugsMesalazine·Infliximab
Ann-Sofie Backman
Phase 2
150
Aalborg, Hvidovre
2022-03-21
Recruiting
Implementation of a Structured Post-pulmonary Embolism Follow-up Model
NCT06037096Pulmonary Embolism
Aalborg University Hospital
Not applicable
2,000
Aalborg
2022-03-15
Recruiting
Navigate - Improving Survival and Quality of Life in Vulnerable Lung Cancer Patients
NCT05053997Lung Cancer
Zealand University Hospital
Not applicable
250
Aalborg, Herning, Odense, Roskilde, Sønderborg, Vejle
2022-03-01
Active, closed
Intravenous Vs. Intraosseous Vascular Access During Out-of-Hospital
NCT05205031Cardiac Arrest
Lars Wiuff Andersen
Phase 4
1,479
Aalborg, Aarhus N, Ballerup Municipality, Næstved, Vejle
2022-03-01
Active, closed
Protons vs. Photons for High-risk Prostate Cancer
NCT05350475Prostate Cancer, Radiotherapy Side Effect
University of Aarhus
Not applicable
102
Copenhagen, Herlev, Aarhus, Aalborg, Næstved, Odense, Vejle
2022-03-01
Recruiting
Prophylactic Antibiotic Treatment in Hemodialysis
NCT05248620Hemodialysis
Zealand University Hospital
Not applicable
800
Copenhagen, Hillerød, Aarhus, Aalborg, Roskilde, Odense
2022-02-14
Active, closed
Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease
NCT05202509Atherosclerotic Cardiovascular Disease
DrugObicetrapib
NewAmsterdam Pharma
Phase 3
9,541
Aalborg, Copenhagen, Esbjerg, Herning, Viborg
2022-02-07
Active, closed
Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Mismatch Repair Deficient (dMMR) Advanced or Recurrent Endometrial Carcinoma (MK-3475-C93/KEYNOTE-C93/GOG-3064/ENGOT-en15)
NCT05173987Endometrial Neoplasms
DrugsTaxotere·Paraplatin·Taxol·Keytruda
Merck Sharp & Dohme LLC
Phase 3
280
Copenhagen, Aalborg, Roskilde
2022-02-03
Recruiting
TEENS Multi-site Trial
NCT05179655Self-Injurious Behavior
Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital
Not applicable
356
Aalborg, Odense, Roskilde, Copenhagen
2022-02-01
Active, closed
Study to Assess the Efficacy and Safety of Alpelisib Plus Fulvestrant in Participants With HR-positive (HR+), HER2-negative, Advanced Breast Cancer After Treatment With a CDK4/6 Inhibitor and an Aromatase Inhibitor.
NCT05038735Breast Cancer
DrugsAlpelisib·Fulvestrant
Novartis Pharmaceuticals
Phase 3
210
Aalborg
2021-12-17
Recruiting
Treatment of Adynamic Bone Disorder With Parathyroid Hormone in Chronic Kidney Disease
NCT04522622Adynamic Bone Disease, Chronic Kidney Diseases, Cardiac Disease, Chronic Kidney Disease-Mineral and Bone Disorder
DrugTeriparatide
Ditte Hansen
Phase 4
48
Aalborg, Gentofte Municipality, Herlev, Odense
2021-12-15
Active, closed
A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis
NCT05070858Generalized Myasthenia Gravis
DrugsCemdisiran·Pozelimab
Regeneron Pharmaceuticals
Phase 3
288
Aalborg, Aarhus N, Copenhagen, Odense
2021-12-14
Active, closed
Pembrolizumab/Placebo Plus Paclitaxel With or Without Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer (MK-3475-B96/KEYNOTE-B96/ENGOT-ov65).
NCT05116189Ovarian Cancer, Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms
DrugsDocetaxel·Paclitaxel·Bevacizumab·Pembrolizumab
Merck Sharp & Dohme LLC
Phase 3
643
Aalborg
2021-12-13
Active, closed
Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia
NCT04994717Newly Diagnosed Philadelphia (Ph)-Negative B-cell Precursor Acute Lymphoblastic Leukemia (ALL)
DrugBlinatumomab
Amgen
Phase 3
303
Aalborg, Aarhus N, København Ø, Odense
2021-11-02
Active, closed
A Study of Teclistamab in Combination With Daratumumab Subcutaneously (SC) (Tec-Dara) Versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratumumab SC, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma
NCT05083169Multiple Myeloma
DrugsTeclistamab·Pomalidomide·Bortezomib·Daratumumab
Janssen Research & Development, LLC
Phase 3
587
Aalborg, Aarhus N, Copenhagen, Odense, Vejle
2021-10-14
Recruiting
Imaging Versus Cardiac Biomarker Monitored HER2 Directed Therapy in Patients With Breast Cancer
NCT05406635Cardiotoxicity, HER2-positive Breast Cancer
Odense University Hospital
Not applicable
220
Aalborg, Copenhagen, Herlev, Odense
2021-10-01
Active, closed
Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closing
NCT05059522Advanced Malignancies, NSCLC, Ovarian Cancer, Urothelial Cancer
DrugsCMP 001·Utomilumab·Talazoparib·Axitinib
Pfizer
Phase 3
77
Aalborg
2021-09-29
Active, closed
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
NCT04557462Primary IgA Nephropathy
DrugIptacopan
Novartis Pharmaceuticals
Phase 3
448
Aalborg, Aarhus N, Copenhagen, Odense C
2021-09-20
Active, closed
Selinexor With Alternating Bortezomib or Lenalidomide Plus Dexamethasone in TIE Newly Diagnosed MM Patients
NCT04717700Multiple Myeloma
DrugsNeofordex·Velcade·Selinexor·Bortezomib
Ida Bruun Kristensen
Phase 2
50
Aalborg, Esbjerg, Gødstrup, Odense
2021-08-18
Recruiting
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
NCT04951622Myasthenia Gravis
DrugNipocalimab
Janssen Research & Development, LLC
Phase 3
199
Aalborg, København Ø
2021-07-15
Active, closed
Evaluation of Co-formulated Pembrolizumab/Quavonlimab (MK-1308A) Versus Other Treatments in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Cancer (CRC) (MK-1308A-008/KEYSTEP-008).
NCT04895722Colorectal Cancer
DrugsPembrolizumab/Vibostolimab·MK-4830·Pembrolizumab/Favezelimab·Pembrolizumab/Quavonlimab
Merck Sharp & Dohme LLC
Phase 2
302
Copenhagen, Herning, Aalborg, Odense
2021-06-25
Active, closed
Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)
NCT04862663Locally Advanced (Inoperable) or Metastatic Breast Cancer
DrugsCapivasertib·Ribociclib·Abemaciclib·Palbociclib
AstraZeneca
Phase 3
893
Aalborg, Aarhus N, Hillerød, Odense
2021-05-10
By invitation
Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM
NCT04848506Symptomatic Hypertrophic Cardiomyopathy (HCM)
DrugAficamten
Cytokinetics
Phase 2/3
900
Aalborg, Aarhus, Copenhagen, Odense
2021-05-06
Recruiting
Brain Activity Among Children With Overactive Bladder and Daytime Urinary Incontinence and Healthy Children
NCT05989646Urinary Incontinence, Daytime Wetting, Urination Disorders, Urination Involuntary
Aalborg University Hospital
Not applicable
65
Aalborg, Aarhus, Herning, Hjørring
2021-05-05
Active, closed
Non-inferiority Study of Ocrelizumab and Rituximab in Active Multiple Sclerosis
NCT04688788Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis
DrugsFexofenadine·Ruxience·Paracetamol·Ocrelizumab
Rigshospitalet, Denmark
Phase 3
600
Glostrup Municipality, Aalborg, Aarhus, Esbjerg, Herlev, Hillerød, Holstebro, Kolding
2021-04-28
Active, closed
A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma.
NCT04680052Follicular Lymphoma, Marginal Zone Lymphoma
DrugsTafasitamab·Lenalidomide·Rituximab
Incyte Corporation
Phase 3
654
Aalborg, Aarhus, Odense, Roskilde
2021-04-15
Active, closed
Stress Aortic Valve Index for Assessing Risk in Aortic Valve Stenosis Patients
NCT04514250Aortic Valve Stenosis
Catharina Ziekenhuis Eindhoven
Observational
52
Aalborg
2021-04-14
Recruiting
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
NCT04728893Hematologic Malignancies, Waldenstroms Macroglobulinaemia, Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukaemia
DrugNemtabrutinib
Merck Sharp & Dohme LLC
Phase 2
490
Aarhus N, Aalborg, Roskilde, Odense C
2021-04-05
Active, closed
The Danish Comorbidity in Liver Transplant Recipients Study
NCT04777032Liver Transplantation, Comorbidities and Coexisting Conditions
Rigshospitalet, Denmark
Observational
600
Aalborg, Aarhus, Copenhagen, Odense
2021-03-15
Active, closed
Study of Selinexor in Combination With Ruxolitinib in Myelofibrosis
NCT04562389Myelofibrosis
DrugsSelinexor·Ruxolitinib
Karyopharm Therapeutics Inc
Phase 3
353
Aarhus N, Aalborg
2021-03-11
Active, closed
Ibrutinib Monotherapy Versus Fixed-duration Venetoclax Plus Obinutuzumab Versus Fixed-duration Ibrutinib Plus Venetoclax in Patients With Previously Untreated Chronic Lymphocytic Leukaemia (CLL)
NCT04608318Chronic Lymphoid Leukemia
DrugsIbrutinib·Obinutuzumab·Venetoclax
German CLL Study Group
Phase 3
897
Aalborg, Aarhus, Copenhagen, Esbjerg, Holstebro, Odense, Roskilde, Vejle
2021-03-01
Active, closed
NORTH-REG Dwell-Time Study
NCT04701151Side Effect of Drug
DrugBacillus Calmette-Guerin
Jørgen Bjerggaard Jensen
Phase 4
314
Aarhus, Aalborg, Copenhagen, Herlev, Herning, Odense, Roskilde
2021-02-03
Active, closed
Local Antibiotics for Breast Implants
NCT04731025Implant Complication, Implant Infection, Implant Site Infection, Implant Capsular Contracture
Mikkel Herly
Phase 3
1,003
Aalborg, Aarhus, Copenhagen, Esbjerg, Herlev, Odense, Roskilde, Vejle
2021-01-27
Active, closed
A Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in Relapsed/Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL)
NCT04628494Diffuse Large B-cell Lymphoma
DrugEpcoritamab
Genmab
Phase 3
483
Aalborg, Aarhus, Roskilde, Vejle
2021-01-13
Active, closed
Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)
NCT04634877Endometrial Neoplasms
DrugsKeytruda·Docetaxel·Paclitaxel·Cisplatin
Merck Sharp & Dohme LLC
Phase 3
990
Copehagen, Herlev, Aalborg, Roskilde, Odense
2021-01-10
Active, closed
CLL Induction Treatment With Venetoclax and Ibrutinib, Followed by Ibrutinib and Obinutuzumab in Patients With MRD.
NCT04639362CLL
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 2
85
Aalborg, Herlev, Odense, Roskilde
2020-12-29
Active, closed
Pullback Pressure Gradient (PPG) Global Registry
NCT04789317Chronic Coronary Insufficiency, Non ST Elevation Myocardial Infarction
VZW Cardiovascular Research Center Aalst
Observational
982
Aalborg, Aarhus, Copenhagen
2020-12-23
Active, closed
A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer
NCT04607421Neoplasms
DrugsEncorafenib·5-FU·Leucovorin·Cetuximab
Pfizer
Phase 3
841
Aalborg, Vejle, Copenhagen, Herlev, Odense C
2020-12-21
Active, closed
A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05)
NCT04622319HER2-Positive Primary Breast Cancer, Residual Invasive Breast Cancer
DrugsTrastuzumab emtansine·Trastuzumab deruxtecan
Daiichi Sankyo
Phase 3
1,600
Aalborg, Aarhus, Copenhagen, Odense, Syddanmark
2020-12-04
Active, closed
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS)
NCT04548999Multiple Sclerosis
DrugsOcrelizumab·Methylprednisolone
Hoffmann-La Roche
Phase 3
769
Aalborg, Glostrup Municipality
2020-12-03
Not yet open
Maxillary Sinus Floor Augmentation in Diabetic Patients
NCT04543630Jaw, Edentulous, Partially, Diabetes
University of Copenhagen
Not applicable
40
Aalborg, Copenhagen
2020-12-01
Active, closed
Safety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome
NCT04623541Relapsed/Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Richter's Syndrome, Treatment-naïve High Risk Chronic Lymphocytic Leukemia
DrugsEpcoritamab·Pirtobrutinib·Lenalidomide·Venetoclax
Genmab
Phase 1/2
194
Copenhagen, Aalborg, Aarhus, Odense, Roskilde, Vejle
2020-11-25
Active, closed
A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine
NCT04616326Chronic Migraine
DrugGalcanezumab
Eli Lilly and Company
Phase 3
312
Aalborg, Copenhagen
2020-11-25
Active, closed
Assessing Durvalumab and FLOT Chemotherapy in Resectable Gastric and Gastroesophageal Junction Cancer
NCT04592913Gastrointestinal Neoplasms, Esophagogastric Junction
DrugDurvalumab
AstraZeneca
Phase 3
957
Aalborg, København Ø, Odense
2020-11-17
Active, closed
A Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Hormone-Sensitive Prostate Cancer
NCT04557059Prostatic Neoplasms
DrugsLhrha·Apalutamide
Janssen Pharmaceutica N.V., Belgium
Phase 3
691
Aalborg, Aarhus N, Copenhagen N, Herlev
2020-11-12
Recruiting
Partial Oral Antibiotic Treatment for Bacterial Brain Abscess
NCT04140903Brain Abscess, Cerebral Abscess
Henrik Nielsen
Phase 4
400
Aalborg, Aarhus, Copenhagen, Odense
2020-11-06
Rows per page Showing 201–300 of 382
Previous 1 2 3 4 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Danish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 28 September 2026. https://priyalifescience.com/clinical-trials-denmark/city/aalborg?page=3

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Denmark and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,473 studies in total at the last sync on 26 Sep 2026, 19:46 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 382 of those studies with a site in Aalborg.

How many clinical trials are recruiting in Aalborg?

206 of the 382 studies on this page are recruiting new participants as of the 26 Sep 2026, 19:46 UTC sync. A further 23 have not yet opened recruitment, 142 are active but closed to new participants, and 11 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.